Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05910619 · ClinicalTrials.gov registry record · NA

Transcranial Pulse Stimulation of the Brain

A NA study of Aging Well and Mild Dementia, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05910619: Recruiting NA study of Aging Well and Mild Dementia, sponsored by University of Florida.

NCT05910619 is a NA study of Aging Well and Mild Dementia that is actively recruiting participants, run by University of Florida. The registered enrollment target is 20 participants, below the 69-participant average among 7 other Aging Well trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05910619, a NA study of Aging Well and Mild Dementia, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will investigate transcranial pulse stimulation (TPS) as a method of enhancing cognitive and neural function. The study team will apply this low intensity, magnetically pulse technology to key brain regions in a randomized, sham-controlled trial (RCT). The study will determine the magnitude of changes in cognitive function and brain function and structure between a pre- and post-stimulation among 10 typically-aging older adults and 10 patients with mild dementia.

Primary Outcome

The ADAS-Cog-Plus total score is touted as the gold standard measure for outcomes measurement following anti-dementia interventions18, allows for reliable longitudinal data collection, and provides coverage of cognitive domains including orientation, memory, language, and praxis.

Conditions Studied

Aging Well Mild Dementia

Interventions

  • DEVICE Neurolith Transcranial Pulse Stimulation Active
  • DEVICE Neurolith Transcranial Pulse Stimulation Sham

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-02-16
Est. Completion 2026-07-07
Phase NA
University of Florida

1,106 total trials

What NCT05910619 shows while recruiting

NCT05910619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 69-participant average among 7 other Aging Well trials with a reported enrollment target (71% lower).

The record links to 2 conditions, with Aging Well appearing as the primary indexed condition, and to 2 interventions - of which Neurolith Transcranial Pulse Stimulation Active is the first listed.

NCT05910619 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05910619 about?

NCT05910619 is a clinical study titled "Transcranial Pulse Stimulation of the Brain". This study will investigate transcranial pulse stimulation (TPS) as a method of enhancing cognitive and neural function. The study team will apply this low intensity, magnetically pulse technology to key brain regions in a randomized, sham-controlled trial (RCT). The study will determine the magnitu...

What is the current status of trial NCT05910619?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-02-16. Estimated completion is 2026-07-07.

What conditions does trial NCT05910619 study?

This clinical trial studies the following conditions: Aging Well, Mild Dementia.

What interventions are being tested in trial NCT05910619?

The interventions under investigation include: Neurolith Transcranial Pulse Stimulation Active (DEVICE), Neurolith Transcranial Pulse Stimulation Sham (DEVICE).

Who is sponsoring clinical trial NCT05910619?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05910619 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aging Well

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05910619

Source: ClinicalTrials.gov NCT05910619, the US trial registry maintained by the National Library of Medicine. NCT05910619 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.